GATA1 - Transient abnormal myelopoiesis associated with Down Syndrome, somatic
This test is available for the following conditions:
- Conditions > Hematological, somatic > Transient abnormal myelopoiesis associated with Down Syndrome, somatic
This product is also part of the following panels:
- Hemostatic/thrombotic disorders panel
- Inherited bone marrow failure and/or predisposition panel to hematological malignancies
- Iron disorders panel
- Mendelian inherited disorders panel with genome wide CNV analysis
- panel congenital dyserythropoietic anemia (CDAN1, C15orf41, GATA1, SEC23B, KIF23, KLF1, LPIN2)
- Primary immunodeficiencies panel
Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Method
- Sequence analysis of all coding exons and flanking intron-exon boundaries
Disclaimer: Low percentage mosaic/somatic variants in low infiltrated samples cannot be excluded, since Sanger sequencing is not sensitive enough for that purpose.
OMIM:
305371
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Bone marrow